TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26873040

Group type: EXPERIMENTAL
Intervention: Variable long ITI (mean=57 s, range 25-123 s)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short ITI (mean=30+/‐ 5s)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long ITI (mean=57+/‐ 5s)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CS alone trials
Number of subjects: 0
Study: 24879836

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exenatide 10 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22229712

Group type: EXPERIMENTAL
Intervention: 50 mg meperidine in 10 mL of saline (slow intravenous injection over 2 min)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 10 mL of isotonic saline (control group)
Number of subjects: 240
Study: 20822189

Group type: EXPERIMENTAL
Intervention: Targeted personalized drinking feedback (PDF) intervention
Number of subjects: 263

Group type: COMPARATOR
Intervention: Standard (nontargeted) PDF intervention
Number of subjects: 263

Group type: COMPARATOR
Intervention: Education-only (EO) condition
Number of subjects: 263
Study: 16685506

Group type: EXPERIMENTAL
Intervention: Clo‐Sur PAD device (n=60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Manual compression (n=60)
Number of subjects: 120
Study: 16240555

Group type: EXPERIMENTAL
Intervention: Collateral informant assessment
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Collateral verification
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Collateral reports
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Time and expense of collateral data collection
Number of subjects: 1264
Study: 12006918

Group type: EXPERIMENTAL
Intervention: T allele of the hepatic lipase -514 C/T polymorphism in male CHD subjects (n = 490)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: T allele of the hepatic lipase -514 C/T polymorphism in male CHD subjects
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: T allele in male CHD patients
Number of subjects: 562

Group type: COMPARATOR
Intervention: T homozygotes in community control subjects
Number of subjects: 562
Study: 9706925

Group type: EXPERIMENTAL
Intervention: Needle bevel directed cephalad (Group 90)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Needle bevel no rotation (Group 0)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Needle bevel rotated 180 degrees (Group 180)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Needle bevel rotated 270 degrees (Group 270)
Number of subjects: 160
Study: 7881967

Group type: EXPERIMENTAL
Intervention: Recombinant IL-2
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2239141

Group type: EXPERIMENTAL
Intervention: ACTH treatment (100 units intramuscular, tapered over 12 weeks)
Number of subjects: 29
Study: 626839

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0
Study: 31221615

Group type: EXPERIMENTAL
Intervention: Oxytetracycline-impregnated gauze drain
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no drain)
Number of subjects: 200
Study: 28482993

Group type: EXPERIMENTAL
Intervention: Group Teleconference Intervention
Number of subjects: 0
Study: 26486190

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone therapy (0.625 mg/day conjugated equine estrogens with or without 2.5 mg/day medroxyprogesterone acetate)
Number of subjects: 7233

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 7233
Study: 23264012

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: X-Lite video laryngoscope
Number of subjects: 105

Group type: COMPARATOR
Intervention: Direct laryngoscope with Macintosh blade
Number of subjects: 105
Study: 20080928

Group type: EXPERIMENTAL
Intervention: Bupropion sustained release 150 mg b.i.d. (n = 109)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo (n = 109)
Number of subjects: 218
Study: 19207322

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid gel with preincorporated lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyaluronic acid gel alone
Number of subjects: 60
Study: 17995589

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 21
Study: 15018852

Group type: EXPERIMENTAL
Intervention: Famciclovir 750 mg once daily
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Famciclovir 500 mg twice daily
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Famciclovir 250 mg three times daily
Number of subjects: 559

Group type: COMPARATOR
Intervention: Aciclovir 800 mg five times daily
Number of subjects: 559
Study: 10639394

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 25
Study: 9305331

Group type: EXPERIMENTAL
Intervention: Pramipexole (up to 4.5 mg/d, mean daily dose 3.8 mg during maintenance)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study: 8349377

Group type: EXPERIMENTAL
Intervention: atenolol 100 mg x 1
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: sustained-release diltiazem 120 mg x 2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: combination therapy (atenolol + diltiazem)
Number of subjects: 25

Group type: COMPARATOR
Intervention: diltiazem
Number of subjects: 25
Study: 3729382

Group type: EXPERIMENTAL
Intervention: Naloxone 0.1 mg
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Naloxone 0.2 mg
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Naloxone 0.4 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 2
Study: 29496722

Group type: EXPERIMENTAL
Intervention: Calcium (1200 mg/day)
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Calcium + Vitamin D (1200 mg/day calcium and 1000 IU/day vitamin D3)
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Calcium alone
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Calcium + Vitamin D
Number of subjects: 2058
Study: 27796666

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 63
Study: 26121546

Group type: EXPERIMENTAL
Intervention: Xylitol gum chewing (mint-flavored, sugarless) starting 6 hours after surgery, chewed until flatus occurred thrice a day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine postoperative regimen (Control)
Number of subjects: 120
Study: 23403425

Group type: EXPERIMENTAL
Intervention: Polyhexamethylene biguanide (PHMB)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Mupirocin
Number of subjects: 106
Study: 21784047

Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg daily for 4 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (400 mg iron daily for 4 months)
Number of subjects: 55
Study: 19748846

Group type: EXPERIMENTAL
Intervention: Targeted letter
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: General reminder letter
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Control group (no letter)
Number of subjects: 15000
Study: 16531616

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg per day) plus low-dose aspirin (75 to 162 mg per day)
Number of subjects: 15603

Group type: COMPARATOR
Intervention: Placebo plus low-dose aspirin
Number of subjects: 15603

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 15603

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 15603

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 15603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15603
Study: 14744472

Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLX) 20 mg/day
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI) adjusted to an adequate plasma level
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combination of FLX 20 mg/day and DMI
Number of subjects: 39
Study: 11317830

Group type: EXPERIMENTAL
Intervention: Eupatorium laevigatum paste
Number of subjects: 60

Group type: COMPARATOR
Intervention: Triamcinolone 0.1% orabase
Number of subjects: 60
Study: 8695092

Group type: EXPERIMENTAL
Intervention: Doxacurium 75 micrograms/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pipecuronium 123 micrograms/kg
Number of subjects: 20
Study: 1474165

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil 200 mg oral dose during interdialytic period
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil 200 mg oral dose during intradialytic period
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hemodialysis session
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefpodoxime plasma concentration post-hemodialysis
Number of subjects: 6
Study: 6151246

Group type: EXPERIMENTAL
Intervention: Reality-adaptive, supportive (RAS) psychotherapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Exploratory, insight-oriented (EIO) psychotherapy
Number of subjects: 95
Study: 30634687

Group type: EXPERIMENTAL
Intervention: Taurisolo® (grape pomace polyphenolic extract)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28045338

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 27503237

Group type: EXPERIMENTAL
Intervention: Fevipiprant (225 mg twice per day orally)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 25326910

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Bupropion and Placebo (combined analysis)
Number of subjects: 392
Study: 22354133

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 20132916

Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel Hemorrhoidectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bipolar Electro‐cautery Hemorrhoidectomy
Number of subjects: 0
Study: 17158592

Group type: EXPERIMENTAL
Intervention: Gefitinib (ZD1839, Iressa)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erlotinib (OSI-774, Tarceva)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somatic EGFR-activating mutations
Number of subjects: 0
Study: 15899952

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at doses ranging from 0.18-0.37 mg/kg.wk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (in the placebo-controlled study)
Number of subjects: 0
Study: 12153923

Group type: EXPERIMENTAL
Intervention: Doctor's readings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recent clinic readings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doctor's readings in treated patients with poor control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated readings by nurse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated self measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home readings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse readings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient in surgery readings
Number of subjects: 0
Study: 9989408

Group type: EXPERIMENTAL
Intervention: Face perception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transition from perception to motor response
Number of subjects: 0
Study: 7498689

Group type: EXPERIMENTAL
Intervention: Sodium phosphate-based laxative (divided doses: 4 PM and 8 PM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Polyethylene glycol-based electrolyte lavage solution (administered the day before colonoscopy)
Number of subjects: 200
Study: 1452890

Group type: EXPERIMENTAL
Intervention: Sorbitol-containing chewing gum
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sucrose-containing chewing gum
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (1100-ppm-F NaF dentifrice)
Number of subjects: 12
Study: 6231863

Group type: EXPERIMENTAL
Intervention: Dilute sulfuric acid containing sodium sulfate (solution A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 37% phosphoric acid (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dilute sulfuric acid with 10% phosphoric acid (solution B)
Number of subjects: 40
Study: 31167892

Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus Saxagliptin (DAPA + SAXA)
Number of subjects: 643

Group type: COMPARATOR
Intervention: Insulin Glargine (INS)
Number of subjects: 643
Study: 28544600

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (30 mg/kg in 5 min)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 26132306

Group type: EXPERIMENTAL
Intervention: Low-glycaemic load (LGL) diet
Number of subjects: 19

Group type: COMPARATOR
Intervention: Low-fat (LF) diet
Number of subjects: 19
Study: 24045525

Group type: EXPERIMENTAL
Intervention: Experimental techniques in transplant surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established protocols in clinical practice
Number of subjects: 0
Study: 21846692

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy Controls (HCs) with placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy Controls (HCs) with rivastigmine
Number of subjects: 15
Study: 19948449

Group type: COMPARATOR
Intervention: Upfront debulking surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interval debulking surgery after neo-adjuvant chemotherapy
Number of subjects: 0
Study: 16814954

Group type: COMPARATOR
Intervention: 68 Gy
Number of subjects: 553

Group type: COMPARATOR
Intervention: 78 Gy
Number of subjects: 553
Study: 14732183

Group type: EXPERIMENTAL
Intervention: Universal intervention
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Targeted intervention
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Combined universal and targeted interventions
Number of subjects: 37

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 37
Study: 11347660

Group type: EXPERIMENTAL
Intervention: Chewing a very hard gum
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chewing a soft gum
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Empty chewing with no bolus
Number of subjects: 15
Study: 9174971

Group type: EXPERIMENTAL
Intervention: NaO Li Su
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 1556390

Group type: EXPERIMENTAL
Intervention: Exposure to sprayed turf 1 hour after application with clothing (long pants, short-sleeved shirt, socks, closed footwear)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exposure to sprayed turf 1 hour after application without clothing (shorts, short-sleeved shirt, barefoot)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Exposure to sprayed turf 24 hours after application
Number of subjects: 20
Study: 2412069

Group type: EXPERIMENTAL
Intervention: Ketanserin treatment for 9 months
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ketanserin therapy
Number of subjects: 42
Study: 31277331

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) counselling and a coupon for 12 standardised free-of-charge sessions in a sports club
Number of subjects: 217

Group type: COMPARATOR
Intervention: PA counselling and written material
Number of subjects: 217
Study: 28869405

Group type: EXPERIMENTAL
Intervention: Stroke Coach
Number of subjects: 126

Group type: COMPARATOR
Intervention: Attention Control (Memory Training Program)
Number of subjects: 126
Study: 26741729

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus S-1 (GS)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 261
Study: 25355131

Group type: EXPERIMENTAL
Intervention: POWeR Tracker (accessed in weeks 1 and 3)
Number of subjects: 13

Group type: COMPARATOR
Intervention: POWeR (Web-based intervention)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: POWeR Tracker
Number of subjects: 13
Study: 22782201

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) algorithm followed
Number of subjects: 1759

Group type: COMPARATOR
Intervention: Procalcitonin (PCT) algorithm overruled
Number of subjects: 1759
Study: 20456486

Group type: EXPERIMENTAL
Intervention: 100 mg acetylsalicylic acid daily for 7 days
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 18580590

Group type: EXPERIMENTAL
Intervention: Multidisciplinary assessment on admission including medical and cognitive evaluations, physical function, nutritional status, and psychosocial adjustment.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Depression score
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dependent activities of daily living
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Modified Berg Balance Score
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mental status score
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Modified Berg Balance Scale score
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Overall assessment and follow-up
Number of subjects: 48
Study: 15698731

Group type: EXPERIMENTAL
Intervention: D3 lymphadenectomy
Number of subjects: 213

Group type: COMPARATOR
Intervention: D1 lymphadenectomy
Number of subjects: 213
Study: 11834879

Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 10
Study: 10402150

Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No benzodiazepine abuse at the beginning of MMT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzodiazepine types abused
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method of BZD use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reason for BZD use
Number of subjects: 0
Study: 7595712

Group type: COMPARATOR
Intervention: Cisplatin (20 mg/m2) plus Etoposide (100 mg/m2) (VP)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Cisplatin (20 mg/m2), Ifosfamide (1.2 g/m2), and Etoposide (75 mg/m2) (VIP)
Number of subjects: 171
Study: 2135137

Group type: EXPERIMENTAL
Intervention: GaAlAs laser diode treatment (active group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Dummy group (control)
Number of subjects: 67
Study: 380254

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 24
Study: 31585778

Group type: COMPARATOR
Intervention: Docetaxel/prednisone (control arm of 3 trials)
Number of subjects: 1600
Study: 31488083

Group type: EXPERIMENTAL
Intervention: Psycho-oncological group intervention for partners of patients with haemato-oncological diseases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27956455

Group type: EXPERIMENTAL
Intervention: Annual oral azithromycin treatment of the entire community
Number of subjects: 48

Group type: COMPARATOR
Intervention: Biannual treatment of children aged 0-12 years only
Number of subjects: 48
Study: 25884271

Group type: EXPERIMENTAL
Intervention: Positive airway pressure (PAP) at 1,320 m
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Positive airway pressure (PAP) at 2,750 m
Number of subjects: 10

Group type: COMPARATOR
Intervention: No positive airway pressure at 2,750 m
Number of subjects: 10
Study: 23667214

Group type: EXPERIMENTAL
Intervention: DBS surgery
Number of subjects: 255

Group type: COMPARATOR
Intervention: Best Medical Therapy (BMT)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: STN DBS
Number of subjects: 255

Group type: COMPARATOR
Intervention: GPi DBS
Number of subjects: 255
Study: 21829748

Group type: EXPERIMENTAL
Intervention: rDEN1Δ30 vaccine (2 doses, subcutaneous)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (2 doses)
Number of subjects: 60
Study: 19780066

Group type: EXPERIMENTAL
Intervention: Family history of myocardial infarction (MI) in at least one first-degree relative
Number of subjects: 2642

Group type: EXPERIMENTAL
Intervention: Family history of MI in two or more first-degree relatives
Number of subjects: 2642

Group type: EXPERIMENTAL
Intervention: Elevated systolic blood pressure (SBP)
Number of subjects: 2642

Group type: EXPERIMENTAL
Intervention: Elevated diastolic blood pressure (DBP)
Number of subjects: 2642

Group type: EXPERIMENTAL
Intervention: Two or more episodes per week of physical activity
Number of subjects: 2642
Study: 17191270

Group type: EXPERIMENTAL
Intervention: Dementia training with peer support group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dementia training only
Number of subjects: 90

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 90
Study: 15494348

Group type: EXPERIMENTAL
Intervention: Acupuncture plus diclofenac (n = 48)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo acupuncture plus diclofenac (n = 49)
Number of subjects: 97
Study: 11251955

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) alone
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) with levamisole
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) with hepatic irradiation
Number of subjects: 397

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) alone (Group A)
Number of subjects: 397

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) with levamisole (Group A)
Number of subjects: 397
Study: 9572698

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream 5% (n = 64)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (n = 64)
Number of subjects: 128
Study: 8073064

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 ml at 0, 2, 4, 8 and 12 h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no grapefruit juice)
Number of subjects: 10
Study: 3392421

Group type: EXPERIMENTAL
Intervention: Killed whole cell (WC) oral cholera vaccine
Number of subjects: 62285

Group type: EXPERIMENTAL
Intervention: B subunit‐killed whole cell (BS‐WC) oral cholera vaccine
Number of subjects: 62285

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 62285